Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-12-003047
Filing Date
2012-11-06
Accepted
2012-11-06 16:23:42
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1212190.htm 10-Q 658568
2 EXHIBIT 4.1 exhibit_4-1.htm EX-4.1 162041
3 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10125
4 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10754
5 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5748
6 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5889
  Complete submission text file 0001178913-12-003047.txt   4637369

Data Files

Seq Description Document Type Size
7 INSTANCE DOCUMENT psti-20120930.xml EX-101.INS 577283
8 TAXONOMY EXTENSION SCHEMA psti-20120930.xsd EX-101.SCH 48784
9 TAXONOMY EXTENSION CALCULATION LINKBASE psti-20120930_cal.xml EX-101.CAL 38848
10 TAXONOMY EXTENSION LABEL LINKBASE psti-20120930_lab.xml EX-101.LAB 630062
11 TAXONOMY EXTENSION PRESENTATION LINKBASE psti-20120930_pre.xml EX-101.PRE 266924
12 TAXONOMY EXTENSION DEFINITION LINKBASE psti-20120930_def.xml EX-101.DEF 157708
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 121183516
SIC: 2836 Biological Products, (No Diagnostic Substances)